Balaji Amines Limited (BOM:530999)

Market Cap	43.85B
Revenue (ttm)	14.58B
Net Income (ttm)	1.85B
Shares Out	32.40M
EPS (ttm)	57.24
PE Ratio	23.65
Forward PE	18.32
Dividend	11.00 (0.82%)
Ex-Dividend Date	Jul 4, 2024

Volume	7,984
Average Volume	10,691
Open	1,330.75
Previous Close	1,321.95
Day's Range	1,317.05 - 1,349.00
52-Week Range	1,112.00 - 2,550.15
Beta	0.97
RSI	57.78
Earnings Date	May 8, 2025

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Industrial Organic Chemicals
• Founded: 1988
• Employees: 1,084
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530999

Financial Performance

In 2023, Balaji Amines's revenue was 16.42 billion, a decrease of -30.31% compared to the previous year's 23.55 billion. Earnings were 2.05 billion, a decrease of -37.07%.